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Objective: To determine the geographical distribution of hemoglobinopathies in the State
of Pernambuco, to characterize the children with these diseases and to describe factors
associated with their follow-up at the referral center during the period from 2003 to 2010.
Methods: A retrospective, cross-sectional, descriptive study was carried out of 275 medical
records from a total of 302 children with hemoglobinopathies diagnosed by the National
Neonatal Screening Program in the State of Pernambuco in the study period. Microsoft Excel
was used for data processing and analysis. The chi-square and the Fisher test were used for
statistical analysis. The level of signiﬁcance was set at 5%. Terra View software was used to
analyze the geographical distribution of hemoglobinopathies in the State.
Results: A total of 8.9% of the cases of hemoglobinopathies detected in the period were
not followed up at the referral center. For the mothers of children with diseases, this was
their second or third or more pregnancy in 64.2% and 30.2%, respectively. Regarding the
inﬂuence of region of residence and regular medical appointments, the study demonstrated
that children from the Zona daMata, Sertão andVale do São Francisco regions did not attend
45.2%, 50% and 55.6% of their appointments in the outpatient department, respectively.
Conclusions: This study shows that a signiﬁcant number of children do not begin consulta-
tions in the outpatient clinic and even those who started treatment early and who have the
most severe form of the disease, usually miss medical appointments.© 2014 Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published
by Elsevier Editora Ltda. All rights reserved.∗ Corresponding author at: Instituto de Medicina Integral Prof. Fernando
PE, Brazil.
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http://dx.doi.org/10.1016/j.bjhh.2014.05.001
1516-8484/© 2014 Associac¸ão Brasileira de Hematologia, Hemoterapia
reserved.Figueira – IMIP, Rua dos Coelhos, 300, Boa Vista, 50070-550 Recife,
e Terapia Celular. Published by Elsevier Editora Ltda. All rights
er. 20
I
H
e
h
o
w
c
e
w
o
a
l
i
S
i
(
m
a
I
i
b
d
a
m
h
o
i
h
a
H
a
t
v
t
t
s
(
s
i
h
p
s
s
t
i
y
b
t
o
1
trev bras hematol hemot
ntroduction
emoglobinopathies result from mutations in the genes that
ncode the alpha () and beta () globin chains of the
emoglobin molecule (Hb). The abnormal Hb S is the result
f a mutation that leads to the replacement of a glutamic acid
ith a valine at position 6 of the  chain, with consequent
hanges in the Hb molecule.1
In general, all symptomatic clinical forms of the pres-
nce of the Hb S gene, either homozygosis or in combination
ith another variant hemoglobin such as Hb C, or Hb D
r in association with the  thalassemia gene are known
s sickle cell disease (SCD). These are the most preva-
ent forms of all hemoglobinopathies and have the greatest
mpact owing to the seriousness of clinical manifestations.2–4
ickle cell anemia is the form of the disease character-
zed by Hb S homozygosis inherited from both parents
Hb SS).5
The World Health Organization (WHO) estimates that 270
illion people carry genes determining variant hemoglobins
nd that every year 300,000 children are born with SCD.6
t is the most prevalent hereditary disease in Brazil, affect-
ng 25,000–30,000 people, with approximately 3500 children
orn with SCD annually. In the State of Pernambuco, the inci-
ence is 1:1400.7 The disease is thus a public health issue,
ssociated with high infant morbidity and demands regular
edical care, adequate housing and nutrition, and general
ealth care.8
The disease’s clinical variability results froma combination
f hereditary and environmental factors. A newborn with SCD
s generally asymptomatic due to the protective effect of fetal
emoglobin (Hb F) which, during this period of life, represents
round 80% of the total hemoglobin. With the replacement of
b F by an increase in Hb S, clinical manifestations begin to
ppear,9 usually starting at the age of six months and lasting
hroughout the patient’s life.5,10
The ﬁrst years are marked by hemolytic anemia and by
aso-occlusive episodes, dactylitis (inﬂammation of ﬁngers or
oes) or hand-foot syndrome, splenic hypofunction or seques-
ration, and a higher susceptibility to infections.9
Other clinical manifestations may affect SCD children,
uch as thoracic syndrome, cognitive problems, priapism
which may lead to sexual impotence) and damage to organs
uch as the kidneys, the lungs and the eyes, diminishing qual-
ty of life, generating incapacitation, and frequent stays in
ospital for treatment or surgical procedures.11
Neonatal diagnosis, early prophylactic treatment with
enicillin, prophylactic vaccination, follow-up by specialized
ervices with periodic clinical evaluations, hospitalization in
ituations of risk, and early identiﬁcation of splenic sequestra-
ion bymothers and caregivers have contributed to a reduction
n mortality from 25% to approximately 3% in the ﬁrst ﬁve
ears of life.8,12
The National Neonatal Screening Program (NNSP), created
y Resolution GM/MS no. 822/01,13 enabled early diagnosis,
reatment and follow-up of hemoglobinopathies. In the State
f Pernambuco, according to Resolution GMno. 452, of October
8, 200114 children with the diagnosis of SCD have been sent
o a referral center since 2002 to immediately start treatment14;36(4):250–255 251
in a specialized multidisciplinary outpatient department and
a specialized clinic.15
The NNSP includes early treatment and regular outpa-
tient appointments of children after neonatal diagnosis.13,16
It is, however, difﬁcult to achieve this, as several factors lead
patients to miss medical consultations. An understanding of
what hinders treatment has proved a challenge, as there has
been little research on children’s follow-up at the referral cen-
ter after diagnosis at neonatal screening.
The aims of this study were to determine the geo-
graphic distribution of hemoglobinopathies in the State of
Pernambuco, to characterize the children affected and to
describe factors associated to the follow-up at the referral
center in the period from 2003 to 2010.
Methods
A retrospective, cross-sectional, descriptive study was carried
out of 275 (91.5%) medical records of a total of 302 chil-
dren with hemoglobinopathies as diagnosed by the NNSP
in the State of Pernambuco in the period from 2003 to
2010, who started treatment in the referral center, located at
the Pernambuco Hematology and Hemotherapy Foundation
(HEMOPE).
According to Datasus,17 Pernambuco has an area of
98,311km2 and a population of 8,810,318. Between 2003 and
2010, a total of 1,166,189 live births occurred in Pernambuco
and 605,632 newborns were screened at public health care
clinics.
The drawing of blood samples for neonatal screening is car-
ried out at health care units located around the State. Blood
samples are then taken to the Pernambuco Central Labora-
tory (LACEN), where they are processed and analyzed. Positive
results for hemoglobinopathies are sent to the Neonatal
Screening Referral Service, which refers the cases to HEMOPE,
the only referral center in the state that performs treatment
and regular outpatient follow-ups in a specialized multidisci-
plinary outpatient department.
For this study, data collection initially used the
LACEN database; the NNSP identiﬁed 302 children with
hemoglobinopathies. The records of 275 were found at the
referral center and several factors were analyzed: diagnosis,
region of residence, socioeconomic status of the family, age
at ﬁrst medical appointment, regularity of medical appoint-
ments, number of births to the child’s mother, and the
existence of siblings with hemoglobinopathies. Subsequently,
the geographic distribution of the disease in the State was
analyzed.
Microsoft Excel was used for data processing and anal-
ysis. The chi-square and the Fisher tests were used for
statistical analysis. The level of signiﬁcance was set at 5%
(p-value<0.05). Terra View software18 was used to analyze
the geographical distribution of hemoglobinopathies in the
State.
This study was approved by the Human Research Ethics
Committee of the Prof. Fernando Figueira Institute for Inte-
gral Medicine (IMIP) and by the Pernambuco Hematology and
Hemotherapy Foundation (HEMOPE) (protocols no. 2084-11
and 043/2011).
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Table 1 – Region of residence and family income stratiﬁed by age at ﬁrst medical appointment.
Age on ﬁrst medical appointment (months)
1–6 7–12 13–24 25 or more Total
n % n % n % n % n %
Region of residence
Recife 58 79.5 6 8.2 9 12.3 0 0.0 73 100.0
Greater Recife 75 78.9 9 9.5 8 8.4 3 3.2 95 100.0
Zona da Mata 34 81.0 6 14.3 2 4.8 0 0.0 42 100.0
Agreste 25 73.5 8 23.5 0 0.0 1 2.9 34 100.0
Sertão 12 85.7 1 7.1 1 7.1 0 7.1 14 100.0
São Francisco Valley 16 94.1 1 5.9 0 0.0 0 0.0 17 100.0
Family Income (min. wages)
0–1.0 145 78.8 25 13.6 12 6.5 2 1.1 184 100.0
1.01–2.0 51 79.7 6 9.4 6 9.4 1 1.6 64 100.0
Over 2.0 21 95.5 0 0.0 1 4.5 0 0.0 22 100.0
ecordNote: Information on family income was missing from ﬁve medical r
Results
Of all hemoglobinopathy cases detected (n=302) in the study
period, 27 (8.9%) were not being treated in the referral cen-
ter (HEMOPE). Of these, 14 were found in the LACEN database
and the other 13 had been to the Referral Service (Hospital da
Restaurac¸ão), but did not start treatment at HEMOPE. Of all
the detected cases, 20 (6.6%) were found at HEMOPE but were
missing from the LACEN database.
After applying the Fisher test, no signiﬁcant associ-
ation (p-value=0.1) was found between age at the ﬁrst
HEMOPE medical appointment and the place of residence.
Family income had no inﬂuence on age at ﬁrst medical
appointment (p-value=0.464) for families earning up to one
minimum wage, and 78.8% of the children were taken to
the outpatient department during the ﬁrst six months of
life (Table 1). Again, family income had no inﬂuence on
Hemoglobinopathies 
(by regio
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Figure 1 – Geographic distribution of children withs.
missing regular medical appointments at HEMOPE (p-value=
0.227).
The present study shows that, even in cities far from the
State capital, such as the ones in the São Francisco Valley,
94.1% of children have their ﬁrst medical appointment in the
outpatient department within their ﬁrst six months of life.
Of those residing in Recife, 12.3%, have the ﬁrst consultation
between 13 and 24 months after diagnosis.
Figures 1 and 2 show the geographic distribution of
hemoglobinopathies in the State of Pernambuco, according to
the child’s place of residence stratiﬁed by region of the State
and by Recife City Health District, respectively.
Of the children commencing follow-up in the ﬁrst six
months of life, most had sickle cell anemia (Hb SS); this cor-
responds to 79.6% of all cases of hemoglobinopathies. The
level of schooling of parents (p-value=0.168) had no inﬂuence
on the child going to the outpatient unit or on not missing
subsequent medical appointments (p-value=0.691).
in Pernambuco
n)
0 300
18 cases
34 cases
41 cases
46 cases
173 cases
hemoglobinopathies by region of residence.
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The fact that a sibling had a hemoglobinopathy was not
igniﬁcantly associated (p-value=0.213) with the age of the
hild at the time of the ﬁrst medical appointment.
Regular return visits to the referral outpatient unit formed-
cal appointments was considered in respect to the number
f appointments according to type of disease, as well as the
genda of the referral center.
Children with Hb SS and Hb SC returned more frequently
o the outpatient unit, although they missed appointments
ather often. Those with Sß thalassemia or Hb CC missed
ppointments regularly (Table 2).
A total of 74.5% of the families with a child with a
emoglobinopathy did not receive the family allowance given
y the government to poor, elderly or disabled persons. Of
he families that received it, 77.1% had a child with Hb SS.
he ﬁnancial help had no inﬂuence on the regularity of return
isits to the outpatient clinic (p-value=0.543), although those
ho received it hardly ever missed medical appointments.
Of all the children covered by the study (n=275), 76.4%were
rst-borns. Of the mothers who already had children with the
isease, 64.2%were pregnant for a second timeand 30.2%were
regnant for at least the third time.
As for the inﬂuence of the region of residence on regular
eturn visits, the study showed that children living in the Zona
a Mata region missed 45.2% of HEMOPE appointments, com-
ared with 50% of those living in the Sertão and 55.6% of those
rom in the São Francisco Valley region (Figure 3).moglobinopathies in Recife City Health Districts.
Discussion
This study shows that diagnosis of hemoglobinopathies using
the Guthrie test does not guarantee treatment for all affected
children, because 8.9% of positive cases are not being followed
up at the referral center. This may be due to the fact that fetal
hemoglobin strongly inhibits the sickling of red cells and is
present in high percentages during the ﬁrst months of life,
thereby protecting children from the clinical effects of the dis-
ease. As there are no apparent symptoms, the parents do not
go to the outpatient clinic, although they are informed of the
importance of prophylactics and early follow-up.19,20
Other factors that explainwhy childrenmiss appointments
are the quality of information on the disease, the availabil-
ity of transport and the severity of the hemoglobinopathy
diagnosed. Furthermore, it is difﬁcult to carry out the whole
procedure proposed by the NNSP in Pernambuco, as children
with the disease receive the test results at the Central Labora-
tory, go to the referral service and then to the referral center,
which is a complicated procedure.
HEMOPE is the only referral center for the treatment of chil-
dren with hemoglobinopathies in the State. Once the disease
has beendiagnosed, children living in Pernambucomust go for
specialized follow-up in the State capital of Recife. The present
study shows that the region of residence of the children had
no inﬂuence on the date of the ﬁrst medical appointment at
254 rev bras hematol hemoter. 2014;36(4):250–255
Table 2 – Regular return visits to referral center for medical appointments by type of hemoglobinopathy.
Type of hemoglobinopathy
Hb SS Hb SC Sß thalassemia Hb CC
n % n % n % n %
Regular medical appointments
Yes 141.0 73.8 39.0 65.0 10.0 50.0 1.0 25.0
5.0
0.0No 50.0 26.2 21.0 3
Total 191 100.0 60.0 10
the outpatient unit, as 12.3% of the children living in Recife
only showed up nearly a year after diagnosis.
It was also clear that the children living in cities/towns
far from Recife started treatment in the ﬁrst months of life,
but regularly missed subsequent appointments. This result
corroborates other studies,15,21 which suggests that the dis-
tance between the place of residence and the referral center,
together with the cost of transportation and information on
the disease and its treatmentmake it hard not tomissmedical
appointments.
The current study also shows that children with Hb SS
(79.6%), the most severe form of the disease, were taken to
the outpatient unit within the ﬁrst six months of life. Such
results have been conﬁrmed by other studies.22–25 However,
although these children started follow-up early, 26.2% regu-
larly missed appointments or did not follow the treatment
schedule properly. The same occurred in children with other
hemoglobinopathies, such as Hb SC, S thalassemia and Hb
CC.
The reasons for children not going to the outpatient unit
may be because of the difﬁculty to access the service, delayed
diagnosis, a lack of understanding of the disease by the family
and the asymptomatic character of the less severe types of
hemoglobinopathies.24–26
The current study shows that indicators such as the level of
schooling of parents, having a sibling with a hemoglobinopa-
thy, and receipt of ﬁnancial or family support have no
inﬂuence on the time of the child’s ﬁrst medical appoint-
ment or on the regularity of return visits to the outpatient
unit.
These data differ from the results of other studies,19,25,27,28
which showed the inﬂuence of socioeconomic status on the
Recife
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
Area
around
Recife
Zona da
Mata
Figure 3 – Region of residence and regula10.0 50.0 3.0 75.0
20.0 100.0 4.0 100.0
outpatient follow-up, continued prophylactics and treatment
of the disease. This difference suggests that the quality of
information about the disease and its treatment rather than
the family’s socioeconomic status may determine whether
medical appointments will be missed or not.
An analysis of the number of pregnancies of mothers with
children affected by the disease shows that this was the sec-
ondchild formost of them (64.2%)while 30.2%hadno less than
two other children with at least one with SCD. This result may
reﬂect the parents’ lack of understanding of genetic counsel-
ing on the probability of generating a sick child.
Some studies highlight the importance of training health
care professionals on how to responsibly and clearly inform
parents so that conscious reproductive decisions can be
taken.28–30
The current study faced a number of limitations including
insufﬁcient informationonsocioeconomic aspects, difﬁculties
in ﬁnding the clinical records for children who were in differ-
ent neonatal screening units, and data collection from clinical
records without using other sources such as interviews with
users and professionals, which could have provided further
data.
This study shows that a signiﬁcant number of diagnosed
children do not start follow-up at the referral center. Even
those who received early treatment missed some subsequent
medical appointments. In spite of parents having received
genetic counseling, many children are born after the second
pregnancy, which suggests that there is a lack of understand-
ing on the part of the families in relation to the information
provided by healthcare staff.
This demonstrates the need to decentralize follow-up ser-
vices for the disease to other cities/towns in the State, to train
Agreste Sertão São
Francisco
Valley
r return visits to the referral center.
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eams of the government healthcare clinics on how to counsel
amilies in respect to prevention and early treatment, and to
hange the procedures followed by children after diagnosis, so
hat parents will be more willing to visit the referral center.
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